These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12614971)

  • 21. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of degree of obesity on surrogate estimates of insulin resistance.
    Kim SH; Abbasi F; Reaven GM
    Diabetes Care; 2004 Aug; 27(8):1998-2002. PubMed ID: 15277430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity.
    Psyrogiannis AJ; Alexopoulos DK; Kyriazopoulou VE; Vagenakis AG
    Angiology; 1998 Aug; 49(8):607-12. PubMed ID: 9717889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.
    Vinciguerra F; Baratta R; Farina MG; Tita P; Padova G; Vigneri R; Frittitta L
    Acta Diabetol; 2013 Jun; 50(3):443-9. PubMed ID: 23447004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
    Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
    Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
    Lorenzo C; Okoloise M; Williams K; Stern MP; Haffner SM;
    Diabetes Care; 2003 Nov; 26(11):3153-9. PubMed ID: 14578254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect?
    Dhawan J; Bray CL; Warburton R; Ghambhir DS; Morris J
    Br Heart J; 1994 Nov; 72(5):413-21. PubMed ID: 7818957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
    Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.
    Fiorentino TV; Hribal ML; Andreozzi F; Perticone M; Sciacqua A; Perticone F; Sesti G
    Nutr Metab Cardiovasc Dis; 2015 May; 25(5):510-7. PubMed ID: 25813686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.
    McLaughlin T; Allison G; Abbasi F; Lamendola C; Reaven G
    Metabolism; 2004 Apr; 53(4):495-9. PubMed ID: 15045698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the established definition criteria for diagnosing metabolic syndrome between overweight and obese children in Vojvodina].
    Vorgucin I; Vlaski J; Naumović N; Katanić D
    Vojnosanit Pregl; 2011 Jun; 68(6):500-5. PubMed ID: 21818917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
    Meigs JB; Wilson PW; Nathan DM; D'Agostino RB; Williams K; Haffner SM
    Diabetes; 2003 Aug; 52(8):2160-7. PubMed ID: 12882936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
    Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
    Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.